RE:RE:RE:RE:RE:RE:RE:ASCO relevanceI'm glad you found a place to discuss your ideas. Having been around since the original thesis paper, speaks volumes. Most of our questions should be answered in the next month or so. A paradigm shift is possible. The safety profile of pelareorep is - 50% of what the FDA requires for AA. That said there's never been an adverse event, to my knowledge anyway. If Bracelet-1 data shows incredible results, I'd think that would put some pressure on the FDA. I believe the fact is that the AA has been applied for already, and perhaps even accepted. They do have fast track, so they get lots of time with the FDA. All of the recent information, and I'll refer again to the biz development plan. This plan has been right on schedule, not missing any timelines. Bracelet-1, Goblet, AMBUSH, car t. To me it just feels like something is up. In a month or so we'll know what is going to happen here. I think they know, we have to wait. Regards